Stock Update: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) – Vertex to Present at the UBS Healthcare Conference on May 19

[Business Wire] – Vertex Pharmaceuticals Incorporated today announced that Jeffrey Leiden, M.D., Ph.D., Chairman, President & CEO of Vertex will present at the UBS Healthcare Conference in New York, NY on Tuesday, May . . . → Read More: Stock Update: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) – Vertex to Present at the UBS Healthcare Conference on May 19 Similar Articles: Stock Update: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) – FDA staff say Vertex CF combo works, unclear how Company Update (NASDAQ:VRTX): Vertex Reports First Quarter 2015 Financial Results Stock Update (NASDAQ:VRTX): Vertex Announces Data from 12-Week Phase 2 Safety Study of VX-661 in Combination with Ivacaftor in People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation